Patents by Inventor Jed J. Wiltzius

Jed J. Wiltzius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230124464
    Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells to FLT3 are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the FLT3 antigen binding molecules and engineered immune cells.
    Type: Application
    Filed: May 23, 2022
    Publication date: April 20, 2023
    Inventors: Alice BAKKER, Lawren WU, Tara ARVEDSON, Jed J. WILTZIUS, Ruben Alvarez RODRIGUEZ
  • Publication number: 20210163621
    Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells to DLL3 are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the DLL3 antigen binding molecules and engineered immune cells.
    Type: Application
    Filed: April 10, 2019
    Publication date: June 3, 2021
    Applicants: AMGEN INC., KiTe Pharma, Inc.
    Inventors: Michael John Giffin, Melissa THOMAS, Christopher MURAWSKY, Ryan B. CASE, Lawren WU, Jed J. WILTZIUS, Ruben Alvarez RODRIGUEZ, Jun FENG
  • Publication number: 20140371427
    Abstract: Methods for producing an IgG2 antibody preparation enriched for one of several IgG2 structural isoforms, differing by disulfide connectivity in the hinge region of the antibody, are disclosed.
    Type: Application
    Filed: December 7, 2012
    Publication date: December 18, 2014
    Applicant: AMGEN INC.
    Inventors: Thomas M. Dillon, Yi-Te Chou, Yautyan Chen, Pavel Bondarenko, Jed J. Wiltzius, Diana Woehle